Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/103715
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia
Author: Suryani, S.
Bracken, L.
Harvey, R.
Sia, K.
Carol, H.
Chen, I.
Evans, K.
Dietrich, P.
Roberts, K.
Kurmasheva, R.
Billups, C.
Mullighan, C.
Willman, C.
Loh, M.
Hunger, S.
Houghton, P.
Smith, M.
Lock, R.
Citation: Molecular Cancer Therapeutics, 2015; 14(2):364-374
Publisher: American Association for Cancer Research
Issue Date: 2015
ISSN: 1535-7163
1538-8514
Statement of
Responsibility: 
Santi Suryani, Lauryn S. Bracken, Richard C. Harvey, Keith C.S. Sia, Hernan Carol, I-Ming Chen, Kathryn Evans, Philipp A. Dietrich, Kathryn G. Roberts, Raushan T. Kurmasheva, Catherine A. Billups, Charles G. Mullighan, Cheryl L.Willman, Mignon L. Loh, Stephen P. Hunger, Peter J. Houghton, Malcolm A. Smith, and Richard B. Lock
Abstract: Abstract not available
Keywords: Molecular targeted therapy; mutation
Rights: © 2014 American Association for Cancer Research.
DOI: 10.1158/1535-7163.MCT-14-0647
Grant ID: NHMRC
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.